The InviScreen® SARS-CoV-2 Multiplex RT-PCR Test kit is an in vitro diagnostic medical device based on real-time PCR nucleic acid amplification technology for the detection of isolated SARS-CoV-2 RNA from nasal, nasopharyngeal and oropharyngeal exudates obtained from individuals with suspected COVID-19. Together with other relevant clinical and epidemiological data, the results of the detection of viral RNA in human samples serve as an aid to the diagnosis of COVID-19 by qualified health professionals. The kit and its components should primarily be used by properly trained healthcare professionals and laboratory technicians with specific training in in vitro diagnostic procedures, in clinical analysis laboratories.
Specifications | |
---|---|
Sample preparation | For RNA extraction the use of RTP® Pathogen Kit (Art. No. 1050100300) or InviSorb® Spin Universal Kit (Art. No. 1040500300) is recommended |
LOD (Detection Limit) | 2.5 copies/μL |
Specificity | SARS-CoV-2 (ORF1ab, N and E genes) |
No. of tests | 100 |
Technology | qPCR / Real-Time PCR |
Instrument compatibility | Applied Biosystems™ 7500, Agilent AriaMx™, Bio Rad CFX96 Touch™ and CFX96 Touch™ Deep Well |
Dyes | Channels Target: FAM, HEX/VIC and Cal Fluor Red/ROX, Channel IAC: Cy5 |
Certification | CE-IVD (in compliance with EU Directive 98/79/EC on in vitro medical devices) |
Product Name | Package Size | Catalogue No. |
---|---|---|
InviScreen® SARS-CoV-2 RT-PCR 4G | 100 reactions | 6010002200 |